Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 350

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 350
---
 read together with the sections titled “ NorthView’s Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “ Profusa’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other financial information included elsewhere in this proxy statement/prospectus. The pro forma condensed combined financial information may not be useful in predicting the future financial condition and results of operations of New Profusa following the Closing. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors. Description of the Transactions The Merger and accompanying transactions may be summarized as follows: •NorthView entered into the Merger Agreement with Merger Sub and Profusa, pursuant to which, among other things, (i) Merger Sub will merge with and into Profusa, the separate corporate existence of Merger Sub will cease and Profusa will be the surviving corporation and a wholly owned subsidiary of NorthView, and NorthView will be renamed “Profusa, Inc.”; •Upon the consummation of the Merger, Profusa’s equityholders and holders of convertible promissory notes will receive or have the right to receive an aggregate of 15,500,000shares of New Profusa Common Stock (at a deemed value of $10.00 per share), which, in the case of Profusa Awards, will be shares underlying awards based on New Profusa Common Stock, representing a pre -transaction 181

equity value of Profusa of $155.0 million and (b) the Incentive Equity Value (which is expected to be $29,018,330 for purposes of this proxy statement/prospectus), plus (c) the Private Placement Value (which is expected to be $14,867,899 for purposes of this proxy statement/prospectus), plus (d) the Aggregate Exercise Price, minus (e) the Aggregate Company Incentive Amount. Profusa’s equityholders will also have the right to receive an aggregate of up to an additional 3,875,000shares New Profusa Common Stock upon the achievement of certain future milestones (such total number of shares of New Profusa Common Stock, the “Aggregate Merger Consideration”). Accordingly, the following estimated numbers of shares of New Profusa’s common stock will be immediately issued and outstanding, based on Profusa’s capital stock balance as of December31, 2024:

|                                                             |     | Pro Forma Combined 
       (Assuming No 
       Redemptions) |